ORamaVR Medical XR Training Platform

ORamaVR SA is a medical extended reality training company described in a January 2026 business-network article as Geneva-based. It serves medical device companies, simulation centres and hospitals that need to train clinicians on procedures and devices without clinical risk.

The platform has a Creator tool to build simulations in-house, a Custom SIM Service that builds simulations from customer documents, a cloud Virtual Training Center for hosting, tracking and certification, a SIM Library of licensable titles, and JARIA, an AI proctor built into each product. Logos on the site include NHS, Roche, Zimmer and University of Michigan.

• Creator: Build simulations in-house without outside developers.
• Custom SIM Service: Simulations produced from customer documents.
• Virtual Training Center: Cloud runtime for hosting, tracking and certification.
• SIM Library: Licensable simulations, with 84+ validated titles cited.
• JARIA AI proctor: Built-in AI assessment in every product.
• Analytics: Session recordings, multiplayer and multi-site tracking.

Distributors of medical devices in Vietnam can train hospital staff on new equipment in XR. Simulation centres at medical universities can license procedural simulations. Hospital groups can certify clinician competency across multiple sites.

Real-time competency logging and certificate issuance support objective assessment of clinicians. Cloud runtime lets multi-site teams train on any headset around the clock. Medical device makers can scale product training without shipping physical equipment. The press coverage cites company claims of 32% skill gain and 80% error reduction.

Medical device and surgical robotics makers need scalable ways to train clinicians across regions, and XR simulation replaces costly cadaver or on-site sessions. Vietnamese hospitals adopting new devices and device distributors serving Southeast Asia may use such simulation for product training and competency certification.

Late-seed round of 4.5 million USD mixing equity and convertible loans, announced late January to early February 2026, with participation from FORTH-ICS, Starttech Ventures and Sofmedica Ventures. Jan Grund Pedersen appointed Chief Business Officer. Founding year not stated; patents pending.